Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer.
J Thorac Oncol. 2023 Aug;18(8):1017-1030. doi: 10.1016/j.jtho.2023.03.020. Epub 2023 Mar 29.
J Thorac Oncol. 2023.
PMID: 37001858
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).
Meertens M, Muntinghe-Wagenaar MB, Sikkema BJ, Lopez-Yurda M, Retèl VP, Paats MS, Ter Heine R, Schuuring E, Timens W, Touw DJ, van Boven JFM, de Langen AJ, Hashemi SMS, Hendriks LEL, Croes S, van den Heuvel MM, Dingemans AC, Mathijssen RHJ, Smit EF, Huitema ADR, Steeghs N, van der Wekken AJ.
Meertens M, et al. Among authors: sikkema bj.
Front Oncol. 2023 Mar 9;13:1136221. doi: 10.3389/fonc.2023.1136221. eCollection 2023.
Front Oncol. 2023.
PMID: 36969063
Free PMC article.
Item in Clipboard
Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma.
Sikkema BJ, Mathijssen RHJ, Robbrecht DGJ, Perera TPS, Koolen SLW, de Bruijn P.
Sikkema BJ, et al.
J Pharm Biomed Anal. 2024 Mar 15;240:115962. doi: 10.1016/j.jpba.2024.115962. Epub 2024 Jan 4.
J Pharm Biomed Anal. 2024.
PMID: 38211518
Free article.
Item in Clipboard
Cite
Cite